Meet all those you can listen to during the 3 days of the InnoShare 2018 congress.
Three days of meetings with the most prominent personalities from around the world
Luis Diaz, MD
Kierownik of the Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center in New York
Luis Diaz, MD, the Head of the Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center in New York, is an internationally recognized physician-scientist with a special interest in cancer genetics and immuno-oncology. His work has involved the clinical development of tumor-derived DNA as a biomarker for cancer screening, early detection, monitoring, and the measurement of early residual disease.
Dr Diaz has pioneered several diagnostic and therapeutic genomic approaches to cancer, and he specializes in the treatment of pancreatic and colorectal cancers. With colleagues, he developed the basis for a molecular Papanicolaou smear, a promising way to detect early-stage ovarian and endometrial cancers based on genetic markers.
Awards and Training
At Johns Hopkins, Dr. Diaz was Director of the Swim Across America Laboratory and a member of the Ludwig Center for Cancer Genetics and Therapeutics, as well as a member of the groups that received the 2013 American Association for Cancer Research Team Cancer Award for Pancreatic Cancer Sequencing; the 2014 Team Cancer Award for Malignant Brain Tumors; and the 2017 Team Cancer Award for the development of Liquid Biopsies in Cancer. Also in 2017, his team was awarded the Team Cancer Award for Colorectal Cancer. Dr. Diaz will spearhead Stand Up to Cancer’s (SU2C) Colorectal Cancer Dream Team, which has received up to $12 million in funding from SU2C. Dr Luis A. Diaz, Jr., M.D., also Co-Founded Inostics, PapGene and Personal Genome Diagnostics (PGDX), Inc.